Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial.

@article{Albert2002EfficacyAS,
  title={Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial.},
  author={Adelin Albert and C Altabre and Franz Baro and Elena Buendia and Albert Cabero and Mar{\'i}a Jes{\'u}s Cancelo and Camil Castelo-Branco and Philippe Chantre and Magdalena Dur{\'a}n and Javier Haya and Pierre Imbert and David Juli{\`a} and Juan Luis Lanchares and Placido Coto Llaneza and Montserrat Manubens and Antonia Mi{\~n}ano and Francisco J Quereda and Claude Ribes and Francisco Pastor V{\'a}zquez},
  journal={Phytomedicine : international journal of phytotherapy and phytopharmacology},
  year={2002},
  volume={9 2},
  pages={85-92}
}
A multicentric, open, prospective, observational and no-randomized clinical trial was carried out in Spain with 190 postmenopausal women receiving a soy preparation rich in isoflavones (PHYTO SOYA, capsules containing 17.5 mg isoflavones). The main object of the present study was to investigate its efficacy in alleviating the symptomatology derived from the… CONTINUE READING